Spotlight influenza: Estimation of influenza vaccine effectiveness in elderly people with assessment of residual confounding by negative control outcomes, Finland, 2012/13 to 2019/20

dc.contributor.authorBaum Ulrike
dc.contributor.authorKulathinal Sangita
dc.contributor.authorAuranen Kari
dc.contributor.organizationfi=kliininen laitos|en=Department of Clinical Medicine|
dc.contributor.organizationfi=tilastotiede|en=Statistics|
dc.contributor.organization-code1.2.246.10.2458963.20.42133013740
dc.contributor.organization-code1.2.246.10.2458963.20.61334543354
dc.converis.publication-id67644939
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/67644939
dc.date.accessioned2022-10-28T12:46:40Z
dc.date.available2022-10-28T12:46:40Z
dc.description.abstract<p><strong>Background</strong></p><p>Cohort studies on vaccine effectiveness are prone to confounding bias if the distribution of risk factors is unbalanced between vaccinated and unvaccinated study subjects.<br></p><p><strong>Aim</strong></p><p>We aimed to estimate influenza vaccine effectiveness in the elderly population in Finland by controlling for a sufficient set of confounders based on routinely available register data.<br></p><p><strong>Methods</strong></p><p>For each of the eight consecutive influenza seasons from 2012/13 through 2019/20, we conducted a cohort study comparing the hazards of laboratory-confirmed influenza in vaccinated and unvaccinated people aged 65–100 years using individual-level medical and demographic data. Vaccine effectiveness was estimated as 1 minus the hazard ratio adjusted for the confounders age, sex, vaccination history, nights hospitalised in the past and presence of underlying chronic conditions. To assess the adequacy of the selected set of confounders, we estimated hazard ratios of off-season hospitalisation for acute respiratory infection as a negative control outcome.<br></p><p><strong>Results</strong></p><p>Each analysed cohort comprised around 1 million subjects, of whom 37% to 49% were vaccinated. Vaccine effectiveness against laboratory-confirmed influenza ranged from 16% (95% confidence interval (CI): 12–19) to 48% (95% CI: 41–54). More than 80% of the laboratory-confirmed cases were hospitalised. The adjusted off-season hazard ratio estimates varied between 1.00 (95% CI: 0.94–1.05) and 1.08 (95% CI: 1.01–1.15), indicating that residual confounding was absent or negligible.<br></p><p><strong>Conclusion</strong></p><p>Seasonal influenza vaccination reduces the hazard of severe influenza disease in vaccinated elderly people. Data about age, sex, vaccination history and utilisation of hospital care proved sufficient to control confounding.<br><br></p>
dc.identifier.eissn1560-7917
dc.identifier.jour-issn1025-496X
dc.identifier.olddbid178891
dc.identifier.oldhandle10024/161985
dc.identifier.urihttps://www.utupub.fi/handle/11111/29158
dc.identifier.urlhttps://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2021.26.36.2100054
dc.identifier.urnURN:NBN:fi-fe2021110854375
dc.language.isoen
dc.okm.affiliatedauthorAuranen, Kari
dc.okm.discipline112 Statistics and probabilityen_GB
dc.okm.discipline3141 Health care scienceen_GB
dc.okm.discipline112 Tilastotiedefi_FI
dc.okm.discipline3141 Terveystiedefi_FI
dc.okm.internationalcopublicationnot an international co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherEuropean Centre for Disease Prevention and Control (ECDC)
dc.relation.doi10.2807/1560-7917.ES.2021.26.36.2100054
dc.relation.ispartofjournalEurosurveillance
dc.relation.issue36
dc.relation.volume26
dc.source.identifierhttps://www.utupub.fi/handle/10024/161985
dc.titleSpotlight influenza: Estimation of influenza vaccine effectiveness in elderly people with assessment of residual confounding by negative control outcomes, Finland, 2012/13 to 2019/20
dc.year.issued2021

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
eurosurv-26-36-3.pdf
Size:
285.62 KB
Format:
Adobe Portable Document Format
Description:
Publisher's PDF